Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease

Brain Research

Volumn 806, Issue 2, 1998, Pages 271-273

  Kondo, Ikuko ^a   Yamamoto, Mitsutoshi ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Genetic association; Paraoxonase 1 (PON1); Parkinson's disease

Indexed keywords

ARYLDIALKYLPHOSPHATASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE ISOLATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; ESTERASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 0032576016     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00586-1     Document Type: Article

References (15)

1. Adkins S., Gan K.N., Mody M.et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52:1993;598-608.
2. Davies H.G., Richter R.J., Keifer M.et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14:1996;334-336.
3. Humbert R., Adler D.A., Disteche C.M.et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:1993;73-76.
4. Kitada T., Asakawa S., Hattori N.et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
5. Langston J.W., Ballard P., Tetrud J.W.et al. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
6. Morens D.M., Grandinetti A., Reed D.et al. Cigarette smoking and protection from Parkinson's disease: false association or ethiologic clue? Neurology. 45:1995;1041-10511.
7. Nishio E., Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem. Biophys. Res. Commun. 236:1997;289-293.
8. Polymeropoulos M.H., Lavedan C C., Leroy E.et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
9. Ruiz J., Blanche H., James R.W.et al. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 346:1995;869-872.
10. Schwart R.D., Kellar K.J. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science. 220:1983;214-216.
11. Serrato M., Marian A.J. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest. 96:1995;3005-3008.
12. Smith C.A.D., Gough A.C., Leigh P.N.et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 339:1992;1375-1377.
13. Suehiro T., Nakauchi Y., Yamamoto M.et al. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int. J. Cardiol. 57:1996;68-73.
14. Takakubo F., Yamamoto M., Ogawa N.et al. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. J. Neurol. Transm. 103:1996;834-849.
15. Wright S.C., Zhong J., Zheng H.et al. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J. 7:1993;1046-1051.